Article: article from journal or magazin.
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and alpha-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and alpha-synuclein protein levels in brain samples (nine patients). We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and alpha-synuclein protein levels.
Adult, Aged, Aged, 80 and over, Female, Fibroblast Growth Factors/genetics, Humans, Male, Middle Aged, Parkinson Disease/genetics, alpha-Synuclein/genetics
Last modification date